Mental and behavioural disorders due to use of other stimulants, including caffeine

F5_STIMUL

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F15 Hospital discharge: ICD-9 — 3044\|3057 Hospital discharge: ICD-8 — 3046 Cause of death: ICD-10 — F15 Cause of death: ICD-9 — 3044\|3057 Cause of death: ICD-8 — 3046 2 out of 7 registries used, show all original rules.	1153
4. Check minimum number of events None	1153
5. Include endpoints None	1153
6. Filter based on genotype QC (FinnGen only)	1153

Control definitions (FinnGen only)

Control exclude: F5_SUBSNOALCO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F10-F19
Name in latin: Perturbationes mentis et modi se gerendi ex usu aliorum stimulantium (coffeino incluso)

NAME	F5_STIMUL
CONTROL_EXCLUDE	F5_SUBSNOALCO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F15
HD_ICD_9	3044\|3057
HD_ICD_8	3046
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F15
COD_ICD_9	3044\|3057
COD_ICD_8	3046
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Mental and behavioural disorders due to use of other stimulants, including caffeine based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	14032	4086	9842
Only index persons	12674	3871	8803
Unadjusted period prevalence (%)
Whole population	0.23	0.12	0.27
Only index persons	0.28	0.14	0.34
Median age at first event (years)
Whole population	26.36	24.29	27.19
Only index persons	26.26	24.21	27.15

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1153	452	701
Unadjusted period prevalence (%)	0.25	0.15	0.31
Median age at first event (years)	27.13	25.47	28.20

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1054: Matched controls
10540

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

1702.1

323.0

345

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

3633.1

323.0

411

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

23.5

323.0

520

419

N05AH03

ATC

olanzapine; systemic

30.2

323.0

542

357

N05BA01

ATC

diazepam; systemic, rectal

22.3

323.0

524

448

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

+∞

323.0

521

F29

ICD-10 Finland

Unspecified nonorganic psychosis

31.4

323.0

463

256

B18.2

ICD-10 Finland

Chronic viral hepatitis C

860.6

323.0

598

T36

ICD-10 Finland

Poisoning by systemic antibiotics

40.1

323.0

447

190

P19

ICPC

Drug abuse

204.4

323.0

363

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

2061.4

323.0

297

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

4804.9

323.0

345

N05AH04

ATC

quetiapine; oral

19.3

323.0

734

1119

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

22.8

322.1

504

407

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

+∞

306.7

279

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

39.0

293.7

378

149

Z72.2

ICD-10 Finland

Drug use

494.2

269.3

258

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

3010.4

267.3

247

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

21.3

265.0

416

312

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

2929.9

261.6

242

N05BA04

ATC

oxazepam; oral

9.9

234.3

602

1246

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

+∞

232.1

214

N05AX08

ATC

risperidone; systemic

18.2

223.0

369

302

N05CD07

ATC

temazepam; oral

26.5

222.3

318

169

N05AA02

ATC

levomepromazine; systemic

29.8

209.5

288

131

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

+∞

206.2

191

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

+∞

205.1

190

N03AE01

ATC

clonazepam; systemic

23.4

204.4

304

179

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

2412.9

199.5

187

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

+∞

190.5

177

N06AX11

ATC

mirtazapine; oral

7.3

189.1

638

1823

N05BA12

ATC

alprazolam; oral

13.8

188.7

353

370

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

1052.4

185.3

176

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

1988.5

172.8

163

N07BB01

ATC

disulfiram; oral

16.7

168.8

285

229

Z2446

NOMESCO Finland

Social worker

13.4

167.7

315

324

N05AX12

ATC

aripiprazole; systemic

15.0

167.3

297

269

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

31.8

164.6

221

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

34.4

160.4

211

F32.9

ICD-10 Finland

Depressive episode, unspecified

7.9

157.4

429

847

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

1664.9

150.8

143

N03AG01

ATC

valproic acid; systemic, rectal

12.9

147.3

280

288

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

25.3

147.2

211

103

N06AB04

ATC

citalopram; systemic

6.8

145.2

448

1033

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

7.5

137.8

378

729

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

1402.0

130.0

124

P18

ICPC

Medication abuse

189.9

129.7

133

N05AF03

ATC

chlorprothixene; systemic

26.9

129.6

182

N05AH02

ATC

clozapine; systemic

18.9

129.3

205

133

F60.2

ICD-10 Finland

Dissocial personality disorder

290.9

128.1

128

C07AA05

ATC

propranolol; systemic

6.0

127.9

437

1112

Z3231

NOMESCO Finland

Registered nurse

5.6

127.3

480

1373

N05AD01

ATC

haloperidol; systemic

28.9

125.9

173

F20.9

ICD-10 Finland

Schizophrenia, unspecified

21.4

125.7

190

107

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

87.7

124.8

138

N05CF01

ATC

zopiclone; oral

5.6

124.8

464

1299

N06AX16

ATC

venlafaxine; oral

6.5

122.2

377

834

N06AB03

ATC

fluoxetine; oral

8.0

121.3

307

512

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

15.9

120.7

205

158

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

52.0

120.0

144

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

37.4

119.8

154

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

15.8

119.8

204

158

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

+∞

119.0

112

ZY000

NOMESCO Finland

Hospital inpatient

37.6

118.4

152

F15.0

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication

1262.5

118.1

113

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

+∞

118.0

111

F10.25

ICD-10 Finland

Alcohol dependence continuous use

31.3

116.2

156

A46

ICD-10 Finland

Erysipelas

8.6

115.1

275

415

ZY010

NOMESCO Finland

Hospital outpatient

10.6

114.6

239

284

F10.20

ICD-10 Finland

Alcohol dependence currently independent

23.9

113.6

165

F60.9

ICD-10 Finland

Personality disorder, unspecified

30.0

110.4

150

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

1163.1

109.5

105

F11.21

ICD-10 Finland

Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment

+∞

109.3

103

P15

ICPC

Chronic alcohol abuse

16.2

109.1

183

135

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

15.6

109.0

186

143

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

+∞

108.2

102

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

+∞

108.2

102

N05BA02

ATC

chlordiazepoxide; systemic

40.9

108.1

136

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

+∞

107.1

101

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

+∞

107.1

101

N06AB06

ATC

sertraline; oral

6.7

106.0

307

608

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

15.3

105.9

182

142

F15.3

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state

+∞

105.0

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

15.2

102.9

177

138

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

+∞

100.7

SPAT1272

SPAT

Drug screening

59.6

100.0

117

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

25.6

99.4

141

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

10.0

96.9

207

252

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

21.4

96.5

145

N05BE01

ATC

buspirone; oral

18.7

96.4

152

F10.24

ICD-10 Finland

Alcohol depence active use

25.4

94.3

134

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

5.8

94.3

309

704

N05AB03

ATC

perphenazine; systemic, rectal

14.7

93.8

163

129

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

7.3

93.6

247

422

SPAT1265

SPAT

Breathalyser

31.3

93.3

125

R56.8

ICD-10 Finland

Other and unspecified convulsions

9.5

91.3

200

253

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

13.3

91.1

166

146

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

40.2

91.1

115

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

9.5

90.5

199

253

AA1AD

NOMESCO Finland

CT of head and brain

5.3

90.2

323

811

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

8.2

89.9

217

322

N03AX16

ATC

pregabalin; oral

4.8

85.2

338

940

B17.1

ICD-10 Finland

Acute hepatitis C

309.1

85.0

F12.29

ICD-10 Finland

Addiction caused by cannabis UNS

+∞

84.5

N06AB10

ATC

escitalopram; oral

4.1

84.4

434

1548

F61.0

ICD-10 Finland

Mixed personality disorders

21.1

84.3

127

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

9.9

83.9

178

211

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

16.5

83.7

138

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

9.0

83.0

187

246

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

10.0

83.0

175

205

XF400

NOMESCO Finland

ECG with 12 standard connections

6.2

82.8

249

501

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

17.3

82.2

133

EBA00

NOMESCO Finland

Extraction of tooth

3.6

81.7

557

2501

N04AA02

ATC

biperiden; systemic

24.2

81.3

117

3044A

ICD-9 Finland

Drug dependence, Amphetamine and other psychostimulant dependence

+∞

79.2

K04.5

ICD-10 Finland

Chronic apical periodontitis

4.0

78.0

393

1356

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

49.0

77.6

F19.26

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction

+∞

77.0

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

+∞

77.0

IGV01

NOMESCO Finland

Psychiatric network contact

33.7

77.0

101

Z2221

NOMESCO Finland

Medical doctor

3.8

75.8

419

1559

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

14.2

75.3

132

105

F10.09

ICD-10 Finland

Alcohol intoxication UNS

14.8

75.0

129

T74.1

ICD-10 Finland

Physical abuse

12.5

75.0

140

128

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

24.9

74.5

106

F11.30

ICD-10 Finland

Withdrawal symptoms caused by opiates uncomplicated

+∞

73.8

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

+∞

73.8

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

9.1

73.2

163

208

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

26.8

73.2

102

N05AA01

ATC

chlorpromazine; systemic, rectal

34.7

72.9

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

18.0

72.4

115

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

16.2

72.4

120

F19.59

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS

+∞

71.7

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

16.7

71.6

117

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

376.7

71.5

N06AB05

ATC

paroxetine; oral

7.6

71.2

178

273

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.5

70.6

291

819

F12.25

ICD-10 Finland

Dependence caused by cannabis continuous use

+∞

70.6

P29

ICPC

Psychological sympt/compl other

6.3

69.9

204

388

N06AA12

ATC

doxepin; systemic

13.2

69.7

126

107

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

11.4

69.3

135

134

N05CF02

ATC

zolpidem; oral

4.3

68.8

297

872

F12.21

ICD-10 Finland

Dependence caused by cannabis currently independent but staying in a controlling environment

+∞

68.5

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

81.9

68.1

EBA30

NOMESCO Finland

Excision of root of tooth

10.1

67.4

140

157

N03AX09

ATC

lamotrigine; oral

7.2

66.5

173

280

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

7.7

66.5

165

249

F13.21

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment

+∞

66.3

F19.50

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances schizophrenic

+∞

66.3

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

4.6

65.9

264

717

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

24.2

64.9

N05AB01

ATC

dixyrazine; systemic

77.0

64.0

P72

ICPC

Schizophrenia

14.9

63.7

109

IGY02

NOMESCO Finland

Psychiatric monitoring contact

11.6

63.3

122

118

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

18.0

63.1

100

A49.9

ICD-10 Finland

Bacterial infection, unspecified

7.3

62.3

160

253

WX892

NOMESCO Finland

Monitored bed care

8.0

62.0

149

213

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

25.5

61.7

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

4.6

61.5

242

641

P16

ICPC

Acute alcohol abuse

15.1

61.2

104

F12.20

ICD-10 Finland

Dependence caused by cannabis currently independent

+∞

61.0

SPAT1227

SPAT

Substance abuse rehabilitation

27.5

60.9

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

3.0

60.5

674

3952

N05BA06

ATC

lorazepam; systemic, sublingual

10.1

60.0

124

137

WX110

NOMESCO Finland

Local anesthesy

3.5

59.7

877

6185

S01.0

ICD-10 Finland

Open wound of scalp

6.7

59.6

162

277

N03AX12

ATC

gabapentin; oral

4.6

59.0

229

595

F19.09

ICD-10 Finland

Intoxication caused by several drugs in combination and by other psychoactive substances UNS

+∞

58.9

N05AF05

ATC

zuclopenthixol; systemic

28.7

58.7

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.1

58.5

427

1877

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

70.2

58.0

X59

ICD-10 Finland

Exposure to unspecified factor

3.4

56.5

338

1279

Z2445

NOMESCO Finland

Psychologist

7.1

56.4

147

236

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

13.5

56.2

100

F99

ICD-10 Finland

Mental disorder, not otherwise specified

11.3

55.2

107

104

EB1AA

NOMESCO Finland

Tooth X-ray examination

2.8

55.2

715

4485

IFC01

NOMESCO Finland

Withdrawal and replacement therapy for opioid addiction

+∞

54.7

N05AD03

ATC

melperone; systemic

60.8

54.1

F90.0

ICD-10 Finland

Disturbance of activity and attention

6.3

54.0

154

279

IEV99

NOMESCO Finland

Other psychiatric network intervention

30.8

53.9

ZXY60

NOMESCO Finland

2-person team, nurses

30.8

53.9

F15.9

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, unspecified mental and behavioural disorder

+∞

53.6

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

+∞

53.6

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

18.2

53.4

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

5.3

53.4

178

390

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

8.1

53.4

126

174

T40.6

ICD-10 Finland

Poisoning: Other and unspecified narcotics

120.4

53.3

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

26.9

52.7

ZXY49

NOMESCO Finland

Other health care provider

31.1

52.6

F12.24

ICD-10 Finland

Addiction caused by cannabis active addiction

+∞

52.5

N06AX12

ATC

bupropion; oral

4.8

52.4

191

461

SPAT1254

SPAT

Administration of medicine

4.3

52.3

219

607

TPH04

NOMESCO Finland

Cathetrisation of vein

3.7

52.2

267

884

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

21.8

52.2

N05AN01

ATC

lithium; oral

9.7

51.7

109

124

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

5.5

51.6

166

348

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

273.5

51.6

Z3226

NOMESCO Finland

Physiotherapist

3.7

51.4

258

840

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

4.4

51.2

208

559

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

23.7

50.8

-1

NOMESCO Finland

2.7

50.6

526

2824

X57

ICD-10 Finland

Unspecified privation

13.4

50.0

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

46.1

50.0

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

13.6

49.8

K02.1

ICD-10 Finland

Caries of dentine

2.8

49.7

793

5458

TKC20

NOMESCO Finland

Catheterisation of bladder

8.8

49.5

110

137

F05.9

ICD-10 Finland

Delirium, unspecified

37.1

49.4

N06BA04

ATC

methylphenidate; oral

7.0

49.2

128

204

EBA15

NOMESCO Finland

Extraction of large number of teeth

12.9

49.1

WX290

NOMESCO Finland

Other blockade of nerve

2.7

48.6

699

4486

SAA01

NOMESCO Finland

Simple examination of mouth

3.1

48.4

879

6498

EBA05

NOMESCO Finland

Complicated extraction of tooth

3.2

47.7

312

1235

WX730

NOMESCO Finland

Conventional respirator

20.0

46.8

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

63.1

46.7

N02AX02

ATC

tramadol; systemic, rectal

2.7

46.6

428

2106

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

18.1

46.6

P99

ICPC

Psychological disorders other

8.3

46.3

107

142

F19.53

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances polymorphic

+∞

46.2

K08.3

ICD-10 Finland

Retained dental root

6.1

45.9

133

244

S18

ICPC

Laceration/cut

2.7

45.6

423

2087

D72

ICPC

Viral hepatitis

240.2

45.3

P01

ICPC

Feeling anxious/nervous/tense

3.3

45.2

264

957

F11.2

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, dependence syndrome

+∞

45.1

F12.5

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, psychotic disorder

+∞

45.1

F19.22

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication

+∞

45.1

F20.0

ICD-10 Finland

Paranoid schizophrenia

24.2

45.0

Z71.8

ICD-10 Finland

Other specified counselling

2.8

45.0

367

1670

F39

ICD-10 Finland

Unspecified mood [affective] disorder

10.1

44.9

ZXY83

NOMESCO Finland

Social worker in multidisciplinary team

44.5

44.8

S06.0

ICD-10 Finland

Concussion

4.0

44.8

200

582

RS220

NOMESCO Finland

14.5

44.4

T51.0

ICD-10 Finland

Toxic effect: Ethanol

28.8

44.3

F22.0

ICD-10 Finland

Delusional disorder

16.8

44.1

F11.9

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, unspecified mental and behavioural disorder

+∞

44.1

IEY01

NOMESCO Finland

Psychoeducation, individual

17.3

44.0

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

10.0

42.9

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

25.4

42.8

ZXD05

NOMESCO Finland

Urgent procedure

2.7

42.6

399

1959

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

434.3

42.5

IGY99

NOMESCO Finland

Other psychiatric treatment contact

9.2

42.3

107

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

5.9

42.1

124

232

A06AD11

ATC

lactulose; oral

5.0

41.5

142

316

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

6.4

41.4

114

195

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

24.0

41.4

A41.9

ICD-10 Finland

Sepsis, unspecified

13.7

41.1

IFC99

NOMESCO Finland

Other biological psychiatric intervention

149.2

41.1

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

5.5

41.0

130

265

K04.0

ICD-10 Finland

Pulpitis

3.4

40.7

225

774

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

5.6

40.5

124

243

N06AA06

ATC

trimipramine; systemic

13.8

40.1

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

34.1

40.1

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

13.6

39.8

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.3

39.8

228

807

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

28.4

39.8

X78

ICD-10 Finland

Intentional self-harm by sharp object

20.8

39.6

J01FF01

ATC

clindamycin; systemic

2.7

39.5

338

1557

O98.4

ICD-10 Finland

Viral hepatitis complicating pregnancy, childbirth and the puerperium

401.7

39.3

F20

ICD-10 Finland

Schizophrenia

19.5

38.8

NA1AD

NOMESCO Finland

Cervical spine CT examination

7.1

38.2

148

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.5

38.0

418

2211

O35.5

ICD-10 Finland

Maternal care for (suspected) damage to fetus by drugs

138.4

38.0

N06AX03

ATC

mianserin; oral

8.6

37.6

105

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

35.8

37.5

ZYC01

NOMESCO Finland

Remote contact by phone

6.1

37.4

107

192

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

10.3

37.3

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

3.9

37.2

169

494

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

16.8

36.8

N03AF01

ATC

carbamazepine; oral, rectal

7.3

36.7

134

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.3

36.5

522

3132

B18.1

ICD-10 Finland

Chronic viral hepatitis B without delta-agent

131.2

35.9

3043A

ICD-9 Finland

Drug dependence, Cannabis dependence

+∞

35.6

N05AX13

ATC

paliperidone; systemic

20.6

35.6

ZXE10

NOMESCO Finland

More than one and less than three hours

2.5

34.9

360

1819

F41.1

ICD-10 Finland

Generalized anxiety disorder

4.6

34.9

128

305

Z3229

NOMESCO Finland

Other healthcare associate professional

5.0

34.8

118

259

K02.9

ICD-10 Finland

Dental caries, unspecified

12.3

34.5

ZXD35

NOMESCO Finland

Usual procedure

7.2

34.4

128

ZXY82

NOMESCO Finland

Nurse in multidisciplinary team

22.3

33.8

F11.26

ICD-10 Finland

Addiction caused by opiates intermittent drug addiction

+∞

33.5

F19.40

ICD-10 Finland

Withdrawal symptoms with delirium caused by several drugs in combination and by other psychoactive substances without seizures

+∞

33.5

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

26.6

33.4

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

34.4

33.3

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

42.6

33.3

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

14.7

33.2

OAB43

SPAT

0.2

33.1

1949

N06AX21

ATC

duloxetine; oral

3.6

33.0

161

497

F41.09

ICD-10 Finland

UNS Panic Syndrome

5.5

32.8

101

198

Z03

ICPC

Housing/neighbourhood problem

31.9

32.8

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

26.0

32.5

ZXE00

NOMESCO Finland

One hour or less

2.3

32.5

428

2426

F19.51

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances paranoid

+∞

32.5

188

Kela drug reimbursment

Psychosis requiring demanding treatment

13.3

32.4

SGA01

NOMESCO Finland

Tooth opening as first aid

2.6

32.2

280

1278

Z72.1

ICD-10 Finland

Alcohol use

13.7

32.2

T40.2

ICD-10 Finland

Poisoning: Other opioids

326.4

32.0

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

6.0

32.0

166

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

4.2

31.7

128

334

F19.52

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances

+∞

31.4

X84

ICD-10 Finland

Intentional self-harm by unspecified means

40.4

31.4

P74

ICPC

Anxiety disorder/anxiety state

4.9

31.2

108

242

N05CD08

ATC

midazolam; nasal, systemic

15.7

31.1

Y07

ICD-10 Finland

Other maltreatment

12.0

30.9

SPAT1247

SPAT

Outpatient detoxication and monitoring

24.8

30.7

R4110

NOMESCO Finland

Physiotherapy

2.5

30.6

280

1310

SPAT1240

SPAT

Therapeutic discussion

2.9

30.6

215

861

SPAT1307

SPAT

Psychosocial counselling and guidance

3.4

30.5

160

522

KMAK

NOMESCO Finland

2.1

30.5

679

4819

IBZ03

NOMESCO Finland

Addiction psychiatry evaluation

+∞

30.4

F15.4

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state with delirium

+∞

30.4

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

11.5

30.3

D10

ICPC

Vomiting

3.4

30.2

157

509

L17

ICPC

Foot/toe symptom/complaint

2.6

29.9

252

1121

K04.7

ICD-10 Finland

Periapical abscess without sinus

4.5

29.7

112

273

S29

ICPC

Skin symptom/complaint other

3.1

29.5

186

691

M79.6

ICD-10 Finland

Pain in limb

2.3

29.5

359

1941

F19.39

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances UNS

+∞

29.3

F11.39

ICD-10 Finland

Withdrawal symptoms caused by opiates without information about seizures

+∞

29.3

F51.0

ICD-10 Finland

Nonorganic insomnia

2.8

29.3

216

888

F40.1

ICD-10 Finland

Social phobias

5.6

29.2

172

L03.9

ICD-10 Finland

Cellulitis, unspecified

10.0

29.2

F21

ICD-10 Finland

Schizotypal disorder

16.3

29.2

R41.0

ICD-10 Finland

Disorientation, unspecified

16.3

29.2

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

8.4

29.0

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.9

28.9

126

352

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.4

28.9

294

1450

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

23.6

28.9

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

21.8

28.9

R05

ICPC

Cough

2.6

28.7

257

1181

S10

ICPC

Boil/carbuncle

4.6

28.6

105

249

R44.0

ICD-10 Finland

Auditory hallucinations

50.1

28.5

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

7.1

28.4

106

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.6

28.3

104

247

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

9.2

28.3

S61.9

ICD-10 Finland

Open wound of wrist and hand, part unspecified

5.8

28.0

151

N05CD02

ATC

nitrazepam; oral

23.0

28.0

P98

ICPC

Psychosis NOS/other

15.5

28.0

K04.1

ICD-10 Finland

Necrosis of pulp

3.0

27.9

180

679

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

16.1

27.9

N06AB08

ATC

fluvoxamine; oral

9.7

27.7

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

19.0

27.6

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

21.8

27.5

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

3.4

27.4

147

486

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

7.8

27.3

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

8.3

27.2

F12.26

ICD-10 Finland

Addiction caused by cannabis intermittent drug addiction

+∞

27.2

3041A

ICD-9 Finland

Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence

+∞

27.2

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

17.4

26.8

R50.9

ICD-10 Finland

Fever, unspecified

2.9

26.8

186

732

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

99.3

26.8

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

18.5

26.7

WYA30

SPAT

23.1

26.7

ZZA00

NOMESCO Finland

Split skin graft

9.5

26.5

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

17.7

26.3

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3028707) Methadone [Presence] in Urine by Screen method

624

373

35.28

307.65

12.6

1.6

—

(3028300) Cannabinoids [Presence] in Urine

708

1043

16.00

307.65

13.7

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

708

1032

16.18

307.65

13.4

1.4

—

(3011288) Drugs identified in Urine by Screen method

690

650

24.95

307.65

17.8

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

365

94.91

307.65

2.2

1.3

—

(3027944) Amphetamines [Presence] in Urine

687

1020

15.19

307.65

12.2

1.4

—

(4198724)

288

55.30

307.65

4.9

1.3

—

(3027008) Opiates [Presence] in Urine

706

1039

15.95

307.65

13.0

1.4

—

(3016879) Cocaine [Presence] in Urine

700

954

17.13

307.65

13.3

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

679

782

19.69

307.65

12.6

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

717

1849

8.61

301.42

3.8

1.8

1.7

1.4

22.23

650

1702

(3009508) Creatinine [Moles/volume] in Urine

715

2025

7.66

266.59

14.2

3.1

mmol/l

7.2

9.5

19.53

627

1777

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

201

110

21.92

258.54

6.4

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

863

3026

8.36

254.03

5.3

3.2

u/l

48.2

32.0

6.33

807

2885

(3042517) Benzodiazepines panel - Urine

125

140.08

249.40

5.3

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

357

621

7.88

210.04

5.1

2.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

892

3656

7.36

207.42

6.6

5.7

umol/l

9.5

11.2

7.32

849

3474

(3017143) Hepatitis C virus Ab [Presence] in Serum

591

1809

5.65

188.75

2.4

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

598

1895

5.48

181.98

5.2

4.0

90.4

95.1

4.71

575

1854

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

177

412.71

180.96

1.2

1.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

702

2561

5.45

179.26

2.3

1.7

—

(3023368) Bacteria identified in Blood by Culture

527

1564

5.36

171.83

8.6

4.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

223

284

9.50

169.54

2.1

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

449

1190

5.54

166.68

2.1

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

796

3361

5.42

165.50

3.3

2.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

182

204

10.41

152.01

1.4

1.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

676

2676

4.69

147.98

7.2

6.0

mmol/l

1.2

6.67

630

2494

(3024561) Albumin [Mass/volume] in Serum or Plasma

681

2747

4.61

144.42

4.5

5.2

g/l

35.7

37.8

13.39

639

2592

(42870588) Differential panel, method unspecified - Blood

665

2647

4.57

143.31

7.1

6.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

171

193

10.23

141.82

1.4

1.1

—

(40758558) Short blood count panel - Blood

555

1953

4.55

140.71

13.6

7.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1038

5905

8.60

139.55

9.4

6.8

u/l

78.0

72.4

6.41

999

5602

(3021589) Normoblasts [#/volume] in Blood

795

3718

4.67

134.92

13.5

8.2

e9/l

0.0

0.79

632

3045

(3021447) Carbon dioxide [Partial pressure] in Venous blood

260

513

6.25

131.10

3.7

3.6

kpa

6.1

5.9

1.39

235

502

(3002032) Base excess in Venous blood by calculation

258

506

6.28

130.89

3.7

3.6

mmol/l

2.0

1.7

0.47

204

414

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

695

2998

4.32

130.69

7.7

6.5

mmol/l

1.2

7.52

589

2572

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

198

296

7.87

130.35

3.6

mmol/l

24.6

24.0

1.28

174

276

(3019150) Specific gravity of Urine by Refractometry

496

1716

4.32

126.19

9.4

2.8

kg/l

1.0

0.00

214

(3009466) Valproate [Moles/volume] in Serum or Plasma

152

172

10.03

125.44

6.9

5.4

umol/l

388.2

381.7

0.13

131

147

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

102

18.55

125.18

2.0

2.3

nmol/l

139.4

148.9

0.28

(3014111) Lactate [Moles/volume] in Serum or Plasma

256

535

5.87

120.88

8.8

7.8

mmol/l

1.4

0.16

241

515

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

511

1854

4.15

120.72

3.1

2.0

u/l

524.1

328.5

0.89

482

1780

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

177

266

7.68

115.51

2.1

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

887

4814

4.65

114.98

22.3

9.1

e9/l

4.3

4.0

3.71

773

4240

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

308

788

4.97

114.84

3.0

2.7

u/l

25.3

35.2

3.84

265

690

(3024354) Oxygen [Partial pressure] in Venous blood

219

414

6.30

114.64

3.0

2.8

kpa

5.4

5.0

1.60

194

405

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

114

12.93

114.11

1.3

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

245

523

5.68

112.58

1.8

1.4

—

(3000991) Gas panel - Venous blood

235

489

5.78

110.96

10.1

9.5

—

(3006315) Basophils [#/volume] in Blood

817

4249

4.17

110.87

10.1

6.3

e9/l

0.0

0.46

693

3768

(3020191) Ethanol [Moles/volume] in Serum or Plasma

109

13.12

110.33

1.7

1.4

promille

1.1

1.4

0.62

(3001604) Monocytes [#/volume] in Blood

815

4243

4.14

110.15

10.1

6.3

e9/l

0.6

6.56

691

3769

(3022096) Basophils/100 leukocytes in Blood

765

3841

3.95

108.54

9.6

6.5

0.6

0.7

5.30

727

3663

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

188

327

6.67

106.69

1.4

1.3

—

(3013115) Eosinophils [#/volume] in Blood

825

4393

4.09

106.32

12.6

6.7

e9/l

0.2

0.08

713

3966

(3013826) Glucose [Moles/volume] in Serum or Plasma

804

4233

3.97

104.78

7.3

4.5

mmol/l

6.3

6.4

0.59

765

3865

(3018418) pH of Serum or Plasma

476

1784

3.84

104.60

3.0

4.1

7.4

0.29

102

343

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

56.48

104.03

8.1

9.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

249

577

5.23

103.75

2.3

2.5

g/l

0.2

8.56

217

537

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

321

927

4.41

101.53

2.1

1.7

—

(3006504) Eosinophils/100 leukocytes in Blood

769

3984

3.79

101.49

9.8

6.3

2.6

2.8

2.14

730

3793

(3019069) Monocytes/100 leukocytes in Blood

773

4025

3.79

101.06

10.0

6.6

8.2

8.3

0.94

736

3855

(3019198) Lymphocytes [#/volume] in Blood

820

4456

3.91

99.92

10.1

6.3

e9/l

2.2

2.0

7.50

708

4028

(3030467) Casts [#/volume] in Urine by Automated count

472

1836

3.66

96.72

2.9

2.7

e6/l

0.5

0.3

0.97

339

1322

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

254

633

4.86

96.59

2.1

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

257

648

4.82

96.32

2.2

1.6

—

(3042936) Bacteria identified in Isolate by Culture

323

985

4.17

94.25

2.7

2.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

113

126

9.83

93.74

2.2

4.1

umol/l

34.3

39.0

1.07

100

112

(36304419) Bacteria [Presence] in Urine

469

1875

3.53

91.11

2.8

2.6

—

(3002030) Lymphocytes/100 leukocytes in Blood

778

4239

3.57

90.92

9.8

6.2

29.9

29.8

0.11

738

4050

(3018010) Neutrophils/100 leukocytes in Blood

769

4174

3.53

90.12

9.7

6.1

55.4

56.0

0.62

732

3996

(3018095) Leukocytes [#/volume] in Urine

560

2521

3.37

89.34

3.5

3.2

e6/l

50.4

67.1

0.32

369

1637

(3032080) INR in Blood by Coagulation assay

521

2247

3.41

89.18

6.1

5.7

inr

1.1

0.76

191

780

(3003396) Base excess in Arterial blood by calculation

234

580

4.81

89.15

9.9

10.1

mmol/l

1.0

0.8

0.14

186

441

(3002582) Erythrocytes [#/volume] in Urine

488

2025

3.44

88.90

3.0

2.8

e6/l

37.4

120.6

0.74

353

1498

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

20.58

88.32

1.7

5.0

umol/l

110.8

228.5

0.88

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

127

184

7.63

84.96

2.1

2.5

ug/l

468.4

325.3

0.28

119

174

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

537

2418

3.29

84.57

2.9

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

229

585

4.64

83.72

10.2

10.0

kpa

5.5

5.0

5.86

218

558

(3027801) Oxygen [Partial pressure] in Arterial blood

229

585

4.64

83.72

10.1

9.9

kpa

11.4

13.7

8.30

218

560

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

513

2308

3.20

79.91

2.0

1.6

pmol/l

96.9

97.4

0.10

293

1308

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

149

274

6.10

79.19

12.3

12.5

mmol/l

24.5

24.0

0.93

134

262

(3014576) Chloride [Moles/volume] in Serum or Plasma

248

710

4.18

77.71

10.0

8.0

mmol/l

104.4

0.01

240

697

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

282

895

3.85

76.30

2.4

2.9

umol/l

7.0

7.2

0.07

219

774

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

110

9.22

74.91

13.6

10.5

mmol/l

0.6

0.22

101

(3015377) Calcium [Moles/volume] in Serum or Plasma

463

2043

3.12

73.32

2.8

2.9

mmol/l

2.3

2.4

1.07

425

1871

(3019309) Folate [Moles/volume] in Red Blood Cells

259

799

3.89

72.74

1.7

1.6

nmol/l

1085.0

1123.2

0.23

192

639

(3021960) Folate [Moles/volume] in Serum or Plasma

327

1203

3.40

69.94

1.5

1.4

nmol/l

16.4

20.1

5.91

304

1076

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

163

365

5.04

69.42

1.6

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

485

2252

2.99

69.34

3.5

2.6

u/l

50.3

55.2

1.01

427

2115

(3031040) Bacteria [#/volume] in Urine by Automated count

796

4849

3.07

68.20

4.3

3.4

e6/l

334.4

278.4

0.08

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

294

1039

3.46

66.74

2.5

2.4

e6/l

3.2

2.4

0.59

120

494

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1019

7286

4.43

64.97

7.3

2.8

u/l

54.6

41.2

5.37

990

7034

(3007853) Bacteria identified in Skin by Aerobe culture

271

926

3.52

64.69

2.3

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

193

528

4.19

63.60

1.3

miu/ml

225.7

237.3

0.12

264

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

298

1093

3.33

63.40

2.4

2.3

e6/l

1.2

0.9

0.51

125

547

(3026782) Osmolality of Urine

326

1270

3.18

62.62

2.5

2.4

mosm/kgh2o

515.1

576.0

3.86

285

1100

(3024928) Oxygen saturation in Venous blood

130

7.51

61.30

2.3

2.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1112

8640

9.07

60.32

24.3

9.5

mmol/l

3.9

0.19

1093

8393

(3012095) Magnesium [Moles/volume] in Serum or Plasma

279

1013

3.31

60.04

2.9

3.9

mmol/l

0.8

0.76

255

970

(3019550) Sodium [Moles/volume] in Serum or Plasma

1108

8593

8.42

59.94

24.5

9.4

mmol/l

139.0

139.6

14.27

1090

8368

(3003458) Phosphate [Moles/volume] in Serum or Plasma

237

783

3.55

59.22

6.3

7.2

mmol/l

1.1

1.0

0.97

225

743

(3000850) Epithelial cells [#/volume] in Urine

324

1334

2.99

55.72

2.5

2.4

e6/l

16.2

6.2

1.12

291

1182

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

918

6605

2.91

48.11

4.8

3.6

pmol/l

14.5

0.04

855

6179

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

8.38

47.28

5.1

6.6

mg/l

9.4

9.2

0.13

(3020779) Urea [Moles/volume] in Serum or Plasma

173

542

3.58

46.26

4.5

9.4

mmol/l

7.2

0.01

164

525

(3052851) Hemolysis interference index of Serum or Plasma

193

5.34

45.84

2.8

2.7

—

(3017509) Phencyclidine [Presence] in Urine

20.02

45.11

4.6

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

135

368

4.02

44.11

1.8

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1022

7937

3.53

44.07

6.2

4.0

mu/l

1.6

2.0

1.21

964

7547

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

23.48

44.03

5.6

2.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

103

6.84

42.06

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1051

8392

3.85

41.41

18.6

8.1

ml/min/173m2

103.6

97.5

19.22

906

6774

(3044889) 12 lead EKG panel

771

5295

2.38

41.07

4.1

2.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

114

294

4.19

40.07

13.1

13.2

—

(3010421) pH of Blood

187

5.01

39.37

4.2

2.9

7.4

2.78

154

(3026008) Bacteria identified in Urine by Culture

313

1480

2.53

39.37

2.8

2.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

158

525

3.33

38.23

9.9

10.9

inr

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

441

2456

2.29

38.10

2.8

2.1

—

(3002385) Erythrocyte distribution width [Ratio]

1014

8049

3.15

37.72

34.9

11.7

13.7

13.3

19.87

1003

7902

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1099

9193

5.17

37.13

22.9

9.6

mg/l

24.1

20.8

3.06

966

6940

(3012501) Base excess in Blood by calculation

157

5.26

37.11

4.5

3.0

mmol/l

2.2

2.1

0.16

107

(40767503) Oxygen content in Capillary blood by calculation

114

5.98

35.83

3.2

2.2

17.3

17.6

0.15

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

258

1177

2.54

34.52

3.5

2.9

ng/l

391.3

719.2

0.67

156

687

(3007566) Smooth muscle Ab [Titer] in Serum

109

303

3.87

34.46

1.1

1.4

titre

124.4

76.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

220

931

2.68

34.32

2.4

2.6

mmol/l

2.4

2.63

187

815

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

458

2697

2.16

33.48

3.0

2.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

217

925

2.66

33.29

1.6

2.8

30.7

29.8

1.35

204

902

(1616796) Gas panel - Central venous blood

145

5.15

33.20

3.7

2.9

—

(21494755) Public health laboratory ask at order entry panel

1982

0.18

32.11

1.3

—

(3021901) Oxygen saturation in Capillary blood

6.62

31.35

2.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

804

5948

2.16

31.11

3.7

3.5

mm/h

11.0

7.5

10.94

740

5614

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

187

4.46

30.94

1.9

1.7

—

(1761868) Lipid panel - Serum or Plasma

223

4222

0.42

30.85

2.6

2.2

—

(3009343) pH of Capillary blood

109

329

3.55

30.48

2.9

7.4

0.05

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

+∞

30.34

2.3

0.0

ug/l

1.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

137

5.05

30.28

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

137

5.05

30.28

1.3

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

395

2269

2.13

30.13

2.6

2.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

106

318

3.57

29.90

2.9

mmol/l

1.9

1.0

2.06

226

(3027945) Reticulocytes/100 erythrocytes in Blood

142

511

3.03

29.78

2.7

3.3

1.7

1.8

0.21

117

463

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

6.14

29.69

5.7

2.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

485

3072

2.00

27.80

2.3

nmol/l

61.1

70.2

12.42

456

2907

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

298

1582

2.19

27.44

2.1

mg/l

3.0

2.7

0.88

242

1386

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1122

9889

6.01

27.43

15.9

7.9

u/l

43.6

31.1

7.04

1104

9659

(3037467) Urinalysis macro (dipstick) panel - Urine

744

5511

1.99

26.48

4.0

3.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

985

8112

2.47

26.48

5.0

3.1

mmol/l

6.0

5.7

4.60

915

7659

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

6.53

26.22

12.7

8.2

u/ml

2914.1

24501.3

0.42

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

8.31

25.72

3.3

3.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

305

1701

2.08

24.33

2.6

2.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1537

0.19

24.30

1.5

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

305

1715

2.06

23.71

2.5

2.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

386

2374

1.94

23.15

3.9

2.5

ng/l

23.5

31.0

0.35

223

1083

(3013512) EKG study

276

1517

2.08

22.70

3.8

2.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

118

451

2.80

22.01

3.4

3.5

mmol/l

1.2

3.22

105

395

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

325

1923

1.96

21.59

1.6

mmol/l

1.9

1.5

3.84

289

1713

(3021387) Prolactin [Units/volume] in Serum or Plasma

150

653

2.49

21.53

2.2

1.6

mu/l

550.7

287.8

4.79

126

591

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

138

4.21

20.80

2.4

2.6

—

(3019060) Gas panel - Arterial blood

315

3.05

20.28

5.0

7.1

—

(3023520) Reticulocytes [#/volume] in Blood

327

3.01

20.16

1.5

3.2

e9/l

72.9

73.9

0.07

229

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

117

474

2.63

19.44

2.3

1.8

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

5.59

19.40

3.0

2.7

33.1

43.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

313

1891

1.90

19.21

1.9

2.0

mg/l

1.1

0.9

1.10

227

1306

(3037121) Protein [Mass/volume] in Urine

230

3.32

19.02

3.3

3.5

g/l

0.2

0.3

0.22

120

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1934

0.35

18.90

1.5

—

(40761536) Microorganisms panel - Urine sediment

150

702

2.31

18.21

3.3

3.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

103

4.40

17.47

1.5

1.7

—

(3011648) Oxygen content in Venous blood

5.75

17.33

1.8

2.3

11.7

12.2

0.24

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

5.20

17.02

1.9

2.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

146

697

2.25

16.87

3.6

2.6

u/l

5175.8

4307.7

0.16

270

(40761511) CBC panel - Blood by Automated count

1091

9874

2.95

16.56

19.7

8.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

153

3.65

16.55

4.4

5.0

mmol/l

3.7

3.8

1.40

146

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1059

0.19

16.28

1.2

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

136

640

2.28

16.24

2.1

4.6

u/l

227.4

231.9

0.14

128

614

(21494815) CD4 cells/100 lymphocytes in Specimen

102

4.13

15.06

2.9

2.5

—

44.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

8.38

14.53

1.6

1.3

e6/l

43759.2

24020.8

0.26

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

490

3588

1.64

14.40

4.0

3.7

—

(3020891) Body temperature

216

3.03

14.28

5.7

4.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

168

908

2.00

13.95

2.3

g/l

2.5

2.4

0.73

145

846

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

5.19

13.68

1.5

—

(3012441) Differential panel - Pleural fluid

7.71

13.59

1.7

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

128

3.53

13.00

2.4

g/l

133.8

136.7

0.32

(3023199) Leukocytes [#/volume] in Pleural fluid

7.14

12.73

1.6

1.3

e6/l

54577.9

2444.8

0.48

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

200

1182

1.84

12.61

1.6

1.5

pmol/l

451.7

20680303.3

1.07

161

1059

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

204

2.94

12.59

1.6

2.1

g/l

1.5

1.3

0.51

186

(3022948) Iron [Moles/volume] in Serum or Plasma

174

987

1.90

12.47

2.3

2.4

umol/l

11.6

15.5

7.34

160

928

(3035350) Ketones [Presence] in Urine by Test strip

528

4032

1.57

12.45

3.0

2.8

estimate

0.0

0.50

136

739

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

6.88

12.32

2.2

1.6

—

(3045788) Cell count panel - Pleural fluid

7.83

12.31

1.6

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

151

828

1.95

11.96

2.4

18.9

26.5

7.69

130

726

(3021601) Nitrite [Presence] in Urine by Test strip

525

4029

1.56

11.95

4.2

3.9

estimate

0.0

0.50

139

776

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

187

1108

1.82

11.64

2.4

2.0

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

188

2.91

11.35

2.5

2.1

ug/l

3.2

1.5

0.64

174

(3009261) Glucose [Presence] in Urine by Test strip

525

4065

1.54

11.26

3.1

2.8

estimate

0.0

0.00

139

731

(3022313) Gas panel - Capillary blood

236

2.67

11.11

2.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.83

11.08

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.83

11.08

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

6.89

11.04

1.5

4.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

175

1041

1.80

10.71

2.4

3.1

ng/l

1497.6

687.1

1.04

134

792

(3030905) Polymorphonuclear cells [#/volume] in Blood

173

2.91

10.59

4.4

4.0

e9/l

4.0

3.9

0.24

173

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

380

2.28

10.55

2.2

2.0

ug/l

6.8

9.6

0.68

349

(3005719) IgG [Mass/volume] in Serum or Plasma

130

708

1.94

10.47

1.2

2.5

g/l

11.9

10.5

2.73

119

637

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

128

694

1.95

10.45

7.2

5.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

175

2.88

10.38

4.8

4.3

55.3

0.01

175

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

111

574

2.03

10.36

2.2

3.5

pmol/l

4.6

4.7

0.40

522

(3016018) Differential panel - Cerebral spinal fluid

3.62

10.25

1.7

—

(3017181) Myelocytes/100 leukocytes in Blood

116

616

1.98

10.05

5.4

4.5

0.3

0.8

3.21

159

(3044290) Cell count panel - Cerebral spinal fluid

207

2.69

10.03

1.6

1.7

—

(3000494) Fungus identified in Specimen by Culture

160

946

1.80

9.96

1.5

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

216

1391

1.68

9.94

2.6

2.1

—

(3051611) Lipemic interference index of Serum or Plasma

4.44

9.83

2.6

3.8

—

(3029937) Albumin [Presence] in Urine by Test strip

293

2043

1.58

9.77

3.3

3.1

estimate

0.0

1.08

134

751

(3021440) Promyelocytes/100 leukocytes in Blood

111

593

1.96

9.45

5.5

4.6

0.0

0.1

1.66

150

(3009214) Lutropin [Units/volume] in Serum or Plasma

105

551

2.00

9.41

1.5

1.4

u/l

6.1

7.1

0.69

465

(3003181) Sodium [Moles/volume] in Urine

4.28

9.41

1.8

1.4

mmol/l

58.6

70.8

0.32

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.20

9.38

1.3

1.9

umol/l

16.6

15.9

0.08

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

21.89

9.36

2.6

2.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

861

7558

1.55

9.30

4.9

3.9

mmol/mol

37.2

37.6

0.68

790

7269

(3001019) Free T4 and TSH panel - Serum or Plasma

782

0.29

9.18

1.6

1.5

—

(3025159) Blasts/100 leukocytes in Blood

107

571

1.96

9.14

5.7

4.6

0.0

0.1

1.41

130

(40768797) Stomach Pathology biopsy report

153

916

1.77

9.11

1.1

1.2

—

(3008295) Osmolality of Serum or Plasma

3.82

9.09

2.6

1.6

mosm/kgh2o

294.7

286.1

0.87

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

224

2.53

9.07

1.6

e6/l

37.2

13.8

0.80

177

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

224

2.53

9.07

1.6

1.7

e6/l

79712.7

1149.6

0.50

184

(3037522) Nuclear Ab [Titer] in Serum

195

1254

1.67

8.96

1.3

1.4

titre

176.0

455.0

7.94

208

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.44

8.94

1.1

—

(3007461) Platelets [#/volume] in Blood

1131

10795

3.50

8.81

40.3

13.7

e9/l

251.0

254.7

0.98

1113

10580

(3023410) Appearance of Cerebral spinal fluid

3.40

8.80

1.7

2.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

106

577

1.92

8.55

4.7

4.3

0.3

0.5

0.94

124

(3028026) IgM [Mass/volume] in Serum or Plasma

102

550

1.94

8.46

1.1

1.8

g/l

1.7

1.2

2.32

510

(3035941) MCH [Entitic mass]

1131

10815

3.40

8.37

40.1

13.6

30.0

30.1

0.58

1122

10719

(3024731) MCV [Entitic volume]

1131

10816

3.39

8.35

40.2

13.6

89.8

89.4

2.17

1122

10721

(3026361) Erythrocytes [#/volume] in Blood

1131

10819

3.38

8.29

40.3

13.6

e12/l

4.6

4.7

12.14

1109

10593

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

14.59

8.21

2.6

1.8

—

(3010813) Leukocytes [#/volume] in Blood

1131

10825

3.35

8.16

40.6

13.7

e9/l

7.5

6.6

41.46

1110

10595

(3000963) Hemoglobin [Mass/volume] in Blood

1131

10826

3.34

8.14

40.6

13.7

g/l

137.6

142.1

17.73

1122

10724

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.91

7.90

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

186

1220

1.63

7.86

3.2

2.3

nmol/l

12.4

14.2

2.33

153

1142

(3051651) Icteric interference index of Serum or Plasma

4.28

7.49

2.8

3.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

627

0.29

7.45

2.7

1.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

143

2.71

7.37

3.3

4.9

u/ml

0.3

0.84

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

111

2.94

7.21

1.1

1.5

g/l

38.6

40.0

0.46

102

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

6.93

7.16

1.5

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

6.93

7.16

1.5

2.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

2.70

6.78

1.1

1.5

g/l

3.1

3.0

0.45

110

(3019832) Treponema pallidum Ab [Presence] in Serum

274

2041

1.45

6.33

2.0

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

340

2.00

6.28

1.2

2.2

g/l

67.6

68.5

0.35

323

(3026480) Teichoate Ab [Titer] in Serum

18.12

6.27

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

2.57

6.15

1.1

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

2.57

6.15

1.1

1.5

g/l

3.6

4.0

1.13

106

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

2.57

6.15

1.1

1.5

g/l

7.5

7.0

0.87

113

(3004809) Band form neutrophils/100 leukocytes in Blood

100

2.84

6.02

2.2

2.5

1.8

1.4

0.22

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.91

6.00

1.2

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

440

1.85

5.98

1.6

1.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

213

2.21

5.79

1.3

1.5

mmol/l

3.8

3.6

0.46

199

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

3.64

5.77

1.2

1.1

iu/ml

323.8

216.6

0.66

(3047181) Lactate [Moles/volume] in Blood

172

2.31

5.51

6.6

9.0

mmol/l

1.1

0.07

145

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

162

2.33

5.32

1.4

1.8

—

(3019225) pH of Specimen

510

1.74

5.31

4.8

3.5

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

11.33

5.29

1.4

1.3

nmol/l

28.0

16.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

210

2.14

5.17

1.1

1.3

—

(40768806) Pleura Pathology biopsy report

4.48

5.04

1.6

1.4

—

(3035880) pH of Pleural fluid

10.07

5.03

1.2

1.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

162

2.26

4.89

1.4

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

273

2118

1.38

4.87

1.3

1.4

g/l

2.3

0.00

146

1434

(3009542) Hematocrit [Volume Fraction] of Blood

1013

9548

1.50

4.84

31.7

9.9

40.7

41.9

6.29

771

8305

(3036481) Cortisol [Moles/volume] in Serum or Plasma

122

812

1.56

4.82

1.9

2.0

nmol/l

374.2

368.1

0.13

106

760

(3012516) Albumin [Mass/volume] in Urine

201

1482

1.43

4.82

3.0

3.6

mg/l

130.5

340.1

1.10

134

1024

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

203

2.11

4.80

1.7

1.5

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

11.50

4.79

1.4

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

115

2.47

4.65

1.4

1.9

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

101

650

1.61

4.61

2.4

1.9

nmol/l

43.3

34.6

2.63

644

(3002621) Streptococcal DNAse B [Units/volume] in Serum

14.07

4.58

1.0

1.4

—

(3016038) Potassium [Moles/volume] in Urine

4.79

4.53

2.0

1.1

mmol/l

36.8

34.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

206

1543

1.41

4.51

3.9

4.4

mg/mmol

25.2

12.5

0.64

134

1072

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

222

2.02

4.51

1.4

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

3.03

4.41

1.0

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

486

1.67

4.31

2.4

1.9

pmol/l

171.4

219.9

3.75

463

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

981

0.58

4.10

1.3

1.5

—

(3013762) Body weight Measured

10.05

4.01

1.0

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

106

2.39

3.92

1.2

1.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

2.91

3.91

2.1

2.0

—

(3025130) Human papilloma virus identified in Specimen

145

2.17

3.89

1.7

—

(40761535) Cells panel - Urine sediment

470

1.64

3.84

2.6

2.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

2.86

3.80

2.1

2.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

280

2259

1.32

3.77

8.3

4.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

102

2.38

3.75

1.1

1.2

u/l

19.8

36.5

0.33

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

359

1.71

3.67

3.5

5.1

ng/l

84.9

83.2

0.05

334

(3023419) Bacteria identified in Sputum by Culture

2.77

3.60

2.2

2.5

—

(3036489) Thrombin time

354

1.70

3.58

1.6

2.8

22.3

20.9

1.41

311

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

2.72

3.50

1.3

1.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

2.91

3.47

1.3

1.9

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

3.12

3.37

1.2

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

3.12

3.37

1.2

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

3.12

3.37

1.2

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

633

0.54

3.31

1.2

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

288

2369

1.29

3.31

1.3

u/ml

2.8

1.7

0.38

660

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

156

2.01

3.27

1.1

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

207

1.86

3.20

2.0

1.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.88

3.20

1.0

1.1

—

(4010399)

453

1.58

3.19

1.2

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

193

1.89

3.18

1.4

ug/g

251.2

312.8

0.97

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.00

3.14

0.0

3.3

—

9.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

118

2.14

3.11

1.3

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

255

1.75

3.05

1.2

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.65

2.97

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.35

2.91

1.8

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.35

2.91

1.8

1.1

89.1

98.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

318

0.40

2.88

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

5.41

2.87

1.1

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.41

2.87

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

345

0.43

2.87

1.2

1.1

u/ml

0.2

1.9

—

145

(3002523) Influenza virus A Ag [Presence] in Specimen

317

0.40

2.86

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

462

4069

1.23

2.86

2.8

ug/l

84.7

107.0

2.86

419

3878

(1002224) Polysomnography panel

639

0.58

2.81

1.2

1.1

—

(3042631) Mycobacterium sp identified in Specimen

2.56

2.79

2.3

3.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

0.00

2.78

0.0

2.7

—

68.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

233

1.74

2.75

2.1

1.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

2.16

2.72

1.5

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

4.23

2.68

3.0

5.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

568

0.57

2.67

1.3

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

414

0.50

2.66

1.5

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.81

2.65

1.5

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

337

1.60

2.64

1.2

1.5

u/ml

—

6.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

176

1398

1.31

2.62

1.3

1.2

iu/ml

27.5

21.6

0.28

421

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

120

2.02

2.62

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.62

2.57

2.2

2.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

594

1.45

2.57

1.2

1.4

iu/l

12.9

18.1

1.44

504

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

522

0.56

2.54

1.3

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

2.62

2.53

2.1

1.5

mg/l

16.7

14.0

—

(36660697) Celiac disease serology panel - Serum

115

862

1.37

2.53

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

520

0.57

2.51

1.3

1.4

—

(3017569) Oxygen content in Arterial blood

3.83

2.46

1.6

4.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

125

1613

0.75

2.45

2.2

2.4

20.1

21.7

0.14

382

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

3.65

2.36

1.3

1.5

u/l

13.8

15.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.65

2.36

1.5

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

523

0.58

2.36

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

522

0.58

2.34

1.3

1.4

—

(3005033) Fetal Nuchal fold Thickness US

432

0.55

2.31

1.3

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

2.87

2.30

1.0

1.3

nmol/l

136.4

147.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

2.24

2.28

1.2

2.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

2.08

2.28

1.7

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

354

1.52

2.18

1.5

1.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

314

1.55

2.17

2.5

2.6

ng/l

121.9

95.8

0.34

262

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

3.02

2.15

1.0

2.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

3.02

2.15

1.0

2.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.38

2.12

2.2

1.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

433

0.57

2.12

1.3

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

443

0.58

2.08

1.3

1.5

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.00

2.06

0.0

1.0

—

4.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.51

2.05

1.3

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.51

2.05

1.3

2.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.51

2.05

1.3

2.3

—

(3044941) Cell count panel - Synovial fluid

2.02

2.01

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

126

1.84

1.99

1.9

1.8

e6/l

14511.9

8964.9

0.44

(3024891) Influenza virus A+B Ag [Presence] in Specimen

362

1.49

1.99

1.2

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

2.74

1.93

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

942

9049

1.22

1.92

4.2

3.4

mmol/l

2.7

3.0

19.32

863

8659

(40768800) Prostate Pathology biopsy report

0.00

1.89

0.0

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

2.10

1.87

1.3

—

68.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.66

1.86

1.6

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.99

1.85

1.7

1.8

—

(4094501)

184

0.43

1.81

1.0

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

2.01

1.70

1.7

1.5

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.00

1.70

0.0

1.9

—

134.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.58

1.61

1.0

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

144

1.68

1.58

1.7

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.01

1.58

1.0

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.70

1.58

1.0

1.3

ug/l

12.6

7.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1.86

1.56

1.4

1.9

—

(40768443) Skin Pathology biopsy report

257

1.49

1.54

1.1

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

141

0.42

1.53

1.2

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

141

0.42

1.53

2.3

6.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

2.60

1.51

1.3

—

64.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

0.00

1.51

0.0

26.6

—

122.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.87

1.50

1.0

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.87

1.50

1.0

2.2

—

(44790048)

1.91

1.49

1.3

1.8

—

(44790047)

1.91

1.49

1.3

1.8

—

(44806118)

1.91

1.49

1.3

1.8

—

(44790049)

1.91

1.49

1.3

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

101

1.79

1.49

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.51

1.45

1.3

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.51

1.45

1.3

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.51

1.45

1.3

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.51

1.45

1.3

2.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

102

1.78

1.45

1.1

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.74

1.43

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.74

1.43

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.74

1.43

1.0

1.2

—

(40768804) Tissue Pathology biopsy report

268

3010

0.86

1.43

1.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

200

0.50

1.43

1.3

1.1

—

(3001556) Androgen free Index in Serum or Plasma

2.42

1.39

1.6

1.2

—

(3005570) Glucose [Moles/volume] in Urine

1.95

1.38

1.3

1.7

—

(3003338) MCHC [Mass/volume]

921

8903

1.17

1.37

36.7

11.6

g/l

333.5

335.5

8.70

916

8841

(3020650) Glucose [Presence] in Urine

0.00

1.34

0.0

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

1.34

0.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

274

1.44

1.34

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

275

1.43

1.32

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

284

1.42

1.31

1.4

1.8

—

297.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.51

1.30

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

244

0.57

1.30

1.1

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

101

1225

0.81

1.26

1.8

1.9

ug/l

0.3

0.6

10.67

489

(42529406) Shigella sp [Presence] in Stool by Culture

278

1.42

1.26

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

2.01

1.23

3.7

2.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1100

0.80

1.21

1.7

1.9

—

(3021788) Differential panel - Synovial fluid

1.71

1.17

1.5

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

126

1.60

1.15

1.1

1.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

241

1.42

1.15

1.8

1.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.34

1.12

5.0

2.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.39

1.09

1.0

1.2

—

(3000012) Reticulocyte production index

2.39

1.09

1.2

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

466

0.72

1.09

1.3

1.5

—

(3045716) Anion gap in Serum or Plasma

2.19

1.08

4.1

2.3

mmol/l

9.3

9.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.13

1.05

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.13

1.05

1.1

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

2.07

1.03

1.0

2.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

369

0.70

1.03

1.3

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

212

0.61

0.98

1.2

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.18

0.98

1.0

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.95

0.97

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.90

0.94

1.7

—

(44813793)

1.72

0.92

1.2

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

2.15

0.91

1.5

2.1

—

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.75

0.90

1.2

2.3

—

(3022145) Colonoscopy Study observation

857

0.82

0.90

1.3

1.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

1.79

0.88

1.3

2.1

31.9

32.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.01

0.87

1.2

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.01

0.87

1.2

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

216

0.64

0.86

1.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.94

0.84

1.0

3.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

526

1.23

0.83

1.3

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

114

0.52

0.83

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

163

1.42

0.82

4.3

2.9

mg/l

25.7

24.9

0.04

101

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

922

9006

1.12

0.81

4.0

3.3

mmol/l

4.4

4.8

30.51

851

8669

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1.73

0.79

1.2

1.1

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.79

0.0

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

0.79

0.0

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.79

0.0

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

0.79

0.0

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

0.79

0.0

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.63

0.78

3.3

1.8

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.77

0.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.76

0.0

1.2

—

(4062490)

1.52

0.75

1.1

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

201

1.35

0.75

1.2

1.3

u/ml

2.3

6.3

1.23

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

117

1.46

0.72

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

638

1.19

0.71

1.0

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

917

8973

1.11

0.71

3.9

3.3

mmol/l

1.2

1.4

18.76

843

8618

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.93

0.70

4.2

2.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

286

0.73

0.70

1.7

1.5

—

(40768441) Liver Pathology biopsy report

1.53

0.68

1.0

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

144

1.40

0.68

1.0

1.1

g/l

1.6

1.4

1.22

126

(3000330) Specific gravity of Urine by Test strip

240

1.30

0.68

2.0

2.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

249

1.29

0.67

2.3

1.8

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

102

1.48

0.67

1.0

1.1

mg/l

291.9

276.6

0.60

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

120

1.42

0.64

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

739

1.16

0.64

1.2

iu/ml

63.3

126.5

1.52

292

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

721

1.16

0.63

3.8

3.0

31.4

28.4

1.37

561

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

104

1.45

0.62

3.6

2.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.64

0.62

2.4

1.9

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1.67

0.61

2.8

3.7

u/ml

28.4

76.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

130

1.39

0.61

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

1.57

0.60

1.3

1.7

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.60

0.0

1.3

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.59

0.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

210

1.29

0.59

1.9

2.3

umol/l

4.0

5.7

1.23

155

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

114

1.41

0.59

1.1

—

(3008898) HLA-B27 [Presence]

528

0.83

0.58

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.47

0.58

1.3

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

152

1386

1.11

0.57

1.5

—

(4281824)

1.67

0.56

1.5

1.2

—

(4024509)

1.58

0.54

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.49

0.53

1.4

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

1.43

0.53

1.2

1.4

—

(4027681)

1.43

0.53

1.5

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.60

0.52

1.0

—

(3025941) Bacteria identified in Stool by Culture

574

0.85

0.51

1.3

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

163

1.29

0.48

1.2

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.52

0.48

1.9

2.4

—

(3045424) Erythrocytes [Presence] in Urine

142

0.70

0.46

1.3

1.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.59

0.45

1.2

2.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

192

1.26

0.45

1.3

1.4

u/l

15.7

14.1

0.13

167

(3022621) pH of Urine by Test strip

423

1.17

0.44

2.8

2.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.45

0.44

4.3

2.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

157

1.28

0.43

1.9

4.9

u/ml

35.1

193.4

1.22

139

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

174

0.74

0.43

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

185

0.75

0.43

1.4

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.52

0.41

2.0

1.7

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

11.8

—

0.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.2

—

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.36

0.41

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

2.4

—

(3011436) Histone Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

186

1.24

0.40

1.0

3.3

nmol/l

0.9

0.03

171

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

260

1.20

0.39

1.7

1.9

—

(4146454)

1.43

0.39

3.2

3.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.43

0.39

2.0

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

130

1401

0.92

0.39

1.8

2.8

ug/g

117.0

123.8

0.07

101

1140

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

344

0.84

0.38

1.5

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1.35

0.37

2.0

1.4

—

6.8

—

(40768793) Breast Pathology biopsy report

116

0.69

0.37

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.29

0.36

1.2

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1.34

0.36

1.1

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.66

0.35

1.0

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.65

0.35

1.0

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

172

1.23

0.34

1.1

2.0

g/l

0.8

0.01

133

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

246

1.18

0.34

1.4

1.9

iu/l

6.8

4.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

274

1.17

0.34

1.1

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

274

1.17

0.34

1.1

1.4

—

18.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1.32

0.34

1.1

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

166

0.78

0.33

1.1

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

238

2491

0.94

0.33

3.2

2.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

176

0.79

0.32

2.1

2.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

334

3222

1.05

0.32

3.4

2.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

647

1.10

0.31

1.2

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.72

0.31

1.0

—

(3037756) Immunofixation for Serum or Plasma

1.32

0.31

1.1

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.32

0.31

1.0

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

100

0.70

0.30

1.0

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

102

1.28

0.30

1.2

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

102

1.28

0.30

1.2

1.8

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

544

1.11

0.30

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

303

0.85

0.29

1.7

1.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.25

0.29

1.1

3.2

u/ml

1070.0

713.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

345

1.14

0.29

1.8

5.1

ug/l

19.6

11.2

0.21

265

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

227

0.83

0.28

1.4

1.5

nmol/l

0.2

0.4

2.99

188

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.32

0.28

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.32

0.28

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.32

0.28

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.32

0.28

1.0

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.32

0.28

1.0

1.2

—

(4268621)

140

1.22

0.27

2.5

2.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

205

1.17

0.27

1.3

1.2

u/ml

2.7

12.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

116

0.77

0.27

3.3

2.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.25

0.27

1.3

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

150

0.80

0.27

1.0

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.27

0.26

1.2

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

171

0.82

0.26

1.3

1.4

pmol/l

49.4

73.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.30

0.26

1.0

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.20

0.25

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

105

1.24

0.25

1.2

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

873

8638

1.04

0.24

3.5

3.1

mmol/l

1.6

1.4

4.51

800

8298

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

202

2099

0.95

0.23

2.3

2.4

ug/l

0.8

1.2

5.28

169

1955

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

181

1.16

0.22

1.2

u/ml

28.0

33.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.19

0.21

4.0

2.3

—

(3016228) CD19 cells/100 cells in Blood

1.19

0.21

4.2

2.4

7.8

9.7

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

28.6

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

0.21

0.0

1.1

—

6.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3018133) Calcium [Moles/volume] in Urine

0.00

0.21

0.0

2.2

—

3.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

0.21

0.0

9.7

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.21

0.0

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1.24

0.21

1.1

1.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.21

0.0

2.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

0.21

0.0

9.2

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

3.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.8

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.20

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.20

0.0

1.6

—

4.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.25

0.20

1.0

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.25

0.20

5.5

2.9

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

558

1.08

0.20

2.4

2.1

ml/min/173m2

74.4

81.3

0.42

205

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1.22

0.19

1.1

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1.22

0.19

1.1

1.4

—

(4035726)

488

0.92

0.19

1.3

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.17

0.18

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1.21

0.17

1.1

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

1.22

0.17

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.75

0.17

1.2

—

(4034850)

253

1.11

0.17

13.6

7.3

—

(4306422)

196

1.12

0.16

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

318

0.91

0.16

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.75

0.15

1.0

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

197

1.12

0.15

1.3

u/ml

3.5

3.9

0.15

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

203

0.88

0.15

1.2

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

308

1.07

0.11

1.1

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.04

0.09

1.0

2.7

ug/l

13.0

531.1

—

(40768446) Kidney Pathology biopsy report

1.04

0.09

1.8

1.6

—

(3049717) Cytology report of Urine Cyto stain

134

0.89

0.08

2.3

1.8

—

(40768795) Lymph node Pathology biopsy report

1.03

0.08

1.0

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

146

1.10

0.08

1.4

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

280

2838

0.98

0.08

1.7

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.78

0.08

1.0

1.1

miu/ml

2097.8

1414.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.08

0.08

1.4

3.2

—

(3017732) Neutrophils [#/volume] in Blood

599

1.04

0.07

5.0

2.2

e9/l

4.3

4.1

0.31

523

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

143

0.91

0.07

2.2

2.6

ug/min

72.4

134.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

347

0.95

0.07

1.6

iu/ml

0.0

0.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

1.05

0.07

2.2

4.9

—

45.6

—

(3003694) ABO and Rh group [Type] in Blood

288

2912

0.99

0.06

1.6

—

(3000492) Spirometry study

109

1113

0.98

0.06

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

186

1842

1.01

0.03

1.9

2.3

umol/l

343.0

3350.3

3.57

156

1707

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

129

0.93

0.03

1.1

1.3

—

(3002256) Pathology report gross observation

861

0.99

0.02

1.1

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

865

8639

1.01

0.01

3.9

3.7

—

(3045414) Leukocytes [Presence] in Urine

303

1.02

0.01

1.2

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

106

0.94

0.01

1.0

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.04

0.00

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

122

0.98

0.00

1.2

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

111

0.99

0.00

4.1

2.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

132

1319

1.00

0.00

1.2

u/ml

11.6

7.9

0.31

580

(3003327) Ova and parasites identified in Stool by Light microscopy

365

1.01

0.00

1.7

1.8

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.0

—

(3051339) Copper [Moles/volume] in Blood

0.00

0.0

1.1

—

14.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.00

0.0

11.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.00

0.00

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.0

5.6

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.4

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

4.8

—

20.8

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3036603) Volume of Urine

0.91

0.00

1.0

1.7

—

2147.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

8.6

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

15.6

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

4.8

—

493.8

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

1.9

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.0

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

0.00

0.0

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

266.8

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3013466) aPTT in Blood by Coagulation assay

0.00

0.0

1.1

—

36.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.0

4.1

—

0.6

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.0

1.0

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

12.7

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

2.7

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.2

—

(3034426) Prothrombin time (PT)

0.96

0.00

1.0

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.0

2.7

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.01

0.00

1.3

2.0

—

(3045142) Bone marrow Pathology biopsy report

1.00

0.00

1.0

1.5

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

0.00

0.0

1.0

—

1.4

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3048879) Bone marrow aspiration report

0.00

0.0

3.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_STIMUL and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_STIMUL	9.742 [6.72, 14.13]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.242

During the follow-up period (1.1.1998 — 31.12.2019), 297 out of 3106 females with F5_STIMUL died.

Males

Parameter	HR [95% CI]	p-value
F5_STIMUL	9.704 [8.62, 10.92]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.024

During the follow-up period (1.1.1998 — 31.12.2019), 1150 out of 6957 males with F5_STIMUL died.

Mortality risk

Mortality risk for people of age

years, who have F5_STIMUL.

N-year risk	Females	Males
1	0.892%	1.823%
5	6.188%	10.148%
10	14.644%	25.694%
15	25.708%	45.373%
20	40.894%	65.742%

Relationships between endpoints

↥

Index endpoint: F5_STIMUL – Mental and behavioural disorders due to use of other stimulants, including caffeine

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Mental and behavioural disorders due to use of other stimulants, including caffeine

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints